Rimonabant 5 mg ODT
Sponsors
Sinfatin S.L.
Conditions
Stroke
Phase 2
Effects of a CB1 Antagonist/Reverse Agonist (Rimonabant) on Functional Recovery in Stroke Patients During Subacute Phase.
Not yet recruitingCTIS2025-521689-86-00
Target: 80Updated: 2026-08-10
Effects of a CB1 Receptor Antagonist/Inverse Agonist (Rimonabant) on Walking Ability in Patients in the Chronic Phase of Stroke
Not yet recruitingCTIS2025-521693-33-00
Target: 80Updated: 2026-08-17